PRS4 Economic Evaluation of the Use of Palivizumab as prophylactic Treatment for the reduction of Complications associated with respiratory Syncytial Virus in Pre-Term Patients

Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1698
https://www.valueinhealthjournal.com/article/S1098-3015(11)03260-8/fulltext
Title : PRS4 Economic Evaluation of the Use of Palivizumab as prophylactic Treatment for the reduction of Complications associated with respiratory Syncytial Virus in Pre-Term Patients
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)03260-8&doi=10.1016/j.jval.2011.08.1698
First page : A565
Section Title : Respiratory-Related Disorders
Open access? : No
Section Order : 1625
Categories :
Tags :
Regions :
ViH Article Tags :